A bipartisan bill would give tax credit to companies that manufacture products resulting from their research.
From R&D to manufacturing, here's one reason to keep an eye on Washington.
Toyota has opened a new, 100-acre, state-of-the-art facility in Plano, Texas.
Take a peek at the new Toyota USA facility in Plano. It's more proof that #manufacturingmatters and is driving job creation, too! LIKE if you agree a strong manufacturing sector is great for Texas.
Recent reports seem to indicate business spending at least will be a tailwind to the U.S. economy, at a time when Congress can’t push through stimulus and the Federal Reserve has been pushing up interest rates.
How is manufacturing contributing to our larger economy?
Paper and plastics manufacturer Lollicup USA Inc. has signed a deal that will make way for the development of a $50 million, 700,000-square-foot manufacturing facility in Rockwall, which will help it expand its logistics capabilities in this part of the country.
#ManufacturingMatters Here's the latest big news coming out of North Texas.
"This is new for us, offering jobs on the spot."
Say it again, #manufacturingmatters. Like and share this exciting news coming out of Lockheed Martin.
Today marks a major victory for patients everywhere. The U.S. House of Representatives has reauthorized the Prescription Drug User Fee Act (PDUFA), which provides the FDA the resources they need to review life-saving therapies in an efficient and timely manner. For the last 25 years, PDUFA has helped move many medicines through the drug approval process, allowing patients to quickly access them. We sincerely thank all of the lawmakers who stood by patients today with their vote and leadership. This action will help save countless lives and help patients now and in the future. #CuresNow
Good news for patients and for the biopharmaceutical manufacturing sector!
Lawmakers in Washington are currently discussing re-authorization of the Prescription Drug User Fee Act (PDUFA), which provides critical funding to help ensure the U.S. Food and Drug Administration has necessary resources to efficiently review and approve new medicines. Since it was first passed in 1992, PDUFA has helped to bring more than 1,500 new medicines to patients in need. That's why pharmaceutical manufacturers agree that we need to tell Congress PDUFA is critical to promoting timely access to safe and effective medicines.
For 25 years, the Prescription Drug User Fee Act (PDUFA) has provided critical funding to the U.S. Food and Drug Administration to ensure it has the tools, resources and staff to efficiently review and approve new medicines -- an issue important to the biopharmaceutical and manufacturing industry here in Texas. Congress is working now to reauthorize this important legislation to support the FDA and continue fostering scientific innovation. Make your voice heard and tell Congress PDUFA is vital to bringing new medicines to patients in need.
Whenever biopharmaceutical experts and policymakers discuss medical innovation, they seem to focus only on drug discovery and development and access.
Here's great perspective on why and how #manufacturingmatters in the biopharmaceutical industry.
Contrary to popular belief, manufacturing isn’t really shrinking, it’s just moved—in many cases, to North Texas. Among Dallas-Fort Worth’s largest industry sectors, manufacturing ranks second, comprising 16.1 percent of economic activity, behind only the finance/insurance/real estate sector, at 18.6...
#ManufacturingMatters Here's more proof.